Last week, researchers dropped a bombshell report on DFNZ, a developing new medicine derived from a class of drugs once ...

As drug overdose deaths in the U.S. continue to skyrocket, advocates and lawmakers are working to pass key legislation to help prevent opioid addiction before it starts. Tens of millions of Americans ...

ASAM released a new implementation guide to integrate substance use disorder care within hospital and emergency department clinical pathways.

The FDA approved prescription suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults, the agency announced Thursday.

During my 30 years in the Indiana Senate, I witnessed numerous pieces of legislation aimed at toughening our drug policies and penalties. In my final years, I authored a series of bills that focused ...

Chronic opioid therapy is often misunderstood as primarily producing euphoria, even in long-term pain patients. In reality, ...

Insurer extends partnership with Yale School of Medicine to provide training to better treat injured workers and curb the opioid crisis “Science and empathy are both critical to addressing the ongoing ...

A novel mu-opioid receptor agonist showed strong analgesia without respiratory depression, tolerance, or significant ...

Is there a safe opioid? Scientists discovered DFNZ, a high-potency nitazene that relieves pain without the risk of overdose ...

A pain management clinic with branches in Kennewick and Spokane Valley is shutting down with little notice. Lynx Healthcare has about 2,000 patients in the two communities. Most are receiving ...

New research from the University of Kansas shows people who experience chronic pain tend to consume cigarettes and ...

During my 30 years in the Indiana Senate, I witnessed numerous pieces of legislation aimed at toughening our drug policies and penalties. In my final years, I authored a series of bills that focused ...